Viking Global Investors LP Roivant Sciences Ltd. Transaction History
Viking Global Investors LP
- $29.9 Billion
- Q1 2025
A detailed history of Viking Global Investors LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Viking Global Investors LP holds 46,013,752 shares of ROIV stock, worth $499 Million. This represents 1.55% of its overall portfolio holdings.
Number of Shares
46,013,752
Previous 47,809,960
3.76%
Holding current value
$499 Million
Previous $566 Million
17.91%
% of portfolio
1.55%
Previous 1.91%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
331Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$713 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$670 Million5.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$442 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$389 Million0.03% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$383 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.64B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...